IL24 and neoplasm: Located on chromosome 1q32 [9], the anti-tumor effects of MDA-7/IL-24 have been validated on cancer cell lines that include melanoma [10], breast cancer [8], [9], [11], [12], prostate cancer [8], [9], [11], [12], hepatocellular carcinoma [13], GBM [14]–[16] and others [8], [9], [11], [12], [17].